Global X - Genomics and Biotechnology ETF (GNOM) |
| 46.4398 1.64 (3.66%) 04-14 16:00 |
| Open: | 46.11 |
| High: | 46.535 |
| Low: | 46.11 |
| Volume: | 5,338 |
| Market Cap: | 52(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 54.35 |
| Resistance 1: | 46.53 |
| Pivot price: | 43.85 |
| Support 1: | 43.20 |
| Support 2: | 41.14 |
| 52w High: | 51.42 |
| 52w Low: | 29.44 |
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 10 Apr 2026
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks
Fri, 10 Apr 2026
Why (GNOM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Mon, 30 Mar 2026
Understanding Momentum Shifts in (GNOM) - Stock Traders Daily
Thu, 26 Mar 2026
IBBQ, GNOM, BIB: Biotech ETFs Offer Exposure to Healthcare Startup Companies - TipRanks
Tue, 17 Mar 2026
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - Yahoo Finance
Mon, 16 Mar 2026
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView — Track All Markets
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
